WOCKPHARMA

Wockhardt Pharma has reported a strong turnaround in FY26

Wockhardt Pharma has reported a strong turnaround in FY26, posting a consolidated net profit of ₹199–317 crore after a loss last year, with Q4 FY26 profits surging to ₹164–167 crore. Shares jumped up to 10% today (May 5, 2026) following the results, trading around ₹1,540 on NSE